News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
27-Jun-2001 - Eli Lilly and Company (NYSE: LLY) and the Singapore Economic Development Board (EDB) announced today that they have entered into an agreement for Lilly to establish a groundbreaking R&D center in Singapore focused on systems biology. Systems biology is a creative approach to studying whole ...
11-May-2001 - When Civil War veteran Col. Eli Lilly founded his tiny company on Pearl Street in Indianapolis in 1876, his mission was to discover and sell scientifically sound formulas that would help alleviate human suffering. While the ranks of employees have swelled from the original three to more than ...
07-May-2001 - Eli Lilly and Company and bioMérieux-Pierre Fabre announced that they have signed a letter of intent to collaborate on eflucimibe, an ACAT inhibitor discovered at bioMérieux-Pierre Fabre's research center in Castres, France. Eflucimibe is being developed for the treatment of atherosclerosis ...
04-Apr-2001 - Eli Lilly and Company and Alkermes, Inc. have announced that they have signed a broad, mutually exclusive agreement to develop inhaled formulations of insulin, including short-acting and long-acting insulin, and other potential products for the treatment of diabetes based on the Alkermes AIR™ ...
14-Mar-2001 - Eli Lilly and Company has announced that Deborah Steelman, a leading national expert in health care policy, will join the company as vice president, corporate affairs. In this capacity, she will lead the company's governmental affairs, public policy, external corporate communications, ...
Lilly Working With FDA to Quickly Resolve Issues
09-Mar-2001 - Eli Lilly and Company (NYSE:LLY) announced today that it is working diligently to address issues raised as a result of a U.S. Food and Drug Administration inspection of its injectable product manufacturing facility in Indianapolis. The inspection cited Current Good Manufacturing Practice ...
27-Feb-2001 - Data were presented yesterday at the 14th annual meeting of the American Association of Geriatric Psychiatry (AAGP) in San Francisco regarding an intramuscular formulation of Zyprexa (olanzapine, Lilly) for the control of agitation associated with dementia. An estimated five percent of ...
14-Feb-2001 - Findings to be published in the upcoming issue of Breast Cancer Research and Treatment show that postmenopausal women with osteoporosis who used Evista® (raloxifene HCl) continued to show significantly lower risk of breast cancer through four years of treatment. Evista, a selective estrogen ...
25-Jan-2001 - Eli Lilly and Company has announced that John C. Lechleiter, Ph.D., senior vice president, pharmaceutical products, has been promoted to executive vice president, pharmaceutical products and corporate development. In addition to his current role of leading the company's late-stage product ...
19-Jan-2001 - The expansion of gender-based research and women’s health-beyond reproductive wellness-has exploded in the past decade by nearly 75 percent!1 Now, more than ever, women are searching the Internet for accurate, easily accessible health care information. To help women chart their journey ...
© 1997-2024 LUMITOS AG, All rights reserved